Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Go on an adventure into unexpected corners of the health and science world each week with award-winning host Maiken Scott. The Pulse takes you behind the doors of operating rooms, into the lab with ...

Thousands of farmers and agribusiness leaders gathered in San Antonio, Texas, for Commodity Classic this week as the challenging ag economy looms over producers. We ask National Sorghum Producers ...